Danaher (NYSE:DHR) Share Price Breaks Below Fifty Day Moving Average – Here’s Why

Danaher Corporation (NYSE:DHR – Get Free Report)’s share price passed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $224.82 and traded as low as $219.92. Danaher shares last traded at $220.4190, with a volume of 3,990,094 shares.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Citigroup increased their price objective on Danaher from $230.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Monday, October 26th. Royal Bank Of Canada increased their target price on Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday, October 5th. Guggenheim raised their target price on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Finally, TD Cowen increased their price target on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $242.91.

Check Out Our Latest Research Report on DHR

Danaher Stock Performance

The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The company has a market cap of $155.07 billion, a P/E ratio of 36.08, a P/E/G ratio of 2.89 and a beta of 0.76. The business has a fifty day moving average of $224.82 and a 200 day moving average of $201.66.

Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The company had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. During the same period in the previous year, the company posted $1.89 earnings per share. The firm’s revenue was up 8.3% on a year-over-year basis. On average, equities analysts predict that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were issued a $0.40 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is currently 26.19%.

Insider Buying and Selling

In other news, EVP Gregory M. Milosevich sold 2,100 shares of the firm’s stock in a transaction on Monday, November 9th. The stock was sold at an average price of $230.62, for a total value of $484,302.00. Following the transaction, the executive vice president directly owned 22,367 shares in the company, valued at $5,158,277.54. This trade represents a 8.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CAO Christopher Bouda sold 7,598 shares of the firm’s stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the transaction, the chief accounting officer directly owned 9,107 shares in the company, valued at approximately $2,136,137.92. The trade was a 45.48% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 10.80% of the company’s stock.

Hedge Funds Weigh In On Danaher

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Stonebrook Private Inc. purchased a new position in shares of Danaher during the 3rd quarter valued at about $250,000. PCM Encore LLC raised its stake in Danaher by 6.5% during the 3rd quarter. PCM Encore LLC now owns 1,334 shares of the conglomerate’s stock worth $296,000 after acquiring an additional 81 shares during the period. Defiance ETFs LLC raised its stake in Danaher by 14.4% during the 3rd quarter. Defiance ETFs LLC now owns 2,940 shares of the conglomerate’s stock worth $651,000 after acquiring an additional 371 shares during the period. Tradewinds LLC. bought a new stake in Danaher during the 3rd quarter worth approximately $258,000. Finally, Advisors Asset Management Inc. purchased a new position in Danaher during the third quarter valued at approximately $2,476,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

About Danaher

(Get Free Report)

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

Featured Articles

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.